The need for additional genetic markers for myelodysplastic syndrome stratification: what does the future hold for prognostication?

Author： Otrock Zaher K   Tiu Ramon V   Maciejewski Jaroslaw P   Sekeres Mikkael A  

Publisher： Informa Healthcare

ISSN： 1747-4086

Source： Expert Review of Hematology, Vol.6, Iss.1, 2013-02, pp. : 59-68

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Liver transplantation at our center: what have we learned? What does the future hold?

By Haberal M.   Tirnaksiz M.B.   Karakayali H.   Arslan G.   Moray G.   Boyacioglu S.   Bilgin N.  

Transplantation Proceedings, Vol. 31, Iss. 8, 1999-12 ,pp. : 3155-3156

Elsevier

Access to resources Recommend Favorite

The significance of the hemochromatosis genetic variants in multiple myeloma in comparison to that of myelodysplastic syndrome

By Várkonyi Judit   Demeter Judit   Tordai Attila   Andrikovics Hajnalka  

Annals of Hematology, Vol. 85, Iss. 12, 2006-12 ,pp. : 869-871

Springer Publishing Company

Access to resources Recommend Favorite

Cytogenetic abnormalities in myelodysplastic syndrome: an overview

By Kawankar Nikesh   Rao Vundinti Babu  

Hematology, Vol. 16, Iss. 3, 2011-05 ,pp. : 131-138

Maney Publishing

Access to resources Recommend Favorite

Concurrent pernicious anemia and myelodysplastic syndrome

By Drabick Joseph J.   Davis Brad J.   Byrd John C.  

Annals of Hematology, Vol. 80, Iss. 4, 2001-04 ,pp. : 243-245

Springer Publishing Company

Access to resources Recommend Favorite

Cytogenetic and Molecular Abnormalities in Myelodysplastic Syndrome

By  

Current Molecular Medicine, Vol. 11, Iss. 8, 2011-11 ,pp. : 678-685

Bentham Science Publishers

Access to resources Recommend Favorite